Barbara Angehrn Pavik
Fortune : 197 007 $ au 30/06/2026
Fortune : 197 007 $ au 30/06/2026
Barbara Angehrn Pavik is an Independent Director at Bellevue Group AG since 2023 and an Independent Non-Executive Director at medmix AG since 2022.
Former roles include Chief Executive Officer at Asceneuron SA and Executive Director & Chief Business Officer at Corden Pharma Fribourg SA. Education includes a graduate degree from the University of St. Gallen.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BELLEVUE GROUP AG 0,15% | 31/12/2025 | 20 593 ( 0,15% ) | 174 619 $ | 30/06/2026 |
MEDMIX AG 0,01% | 31/12/2024 | 2 286 ( 0,01% ) | 22 388 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BELLEVUE GROUP AG | Directeur/Membre du Conseil | 21/03/2023 |
| MEDMIX AG | Directeur/Membre du Conseil | 01/04/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Asceneuron SA
Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Directeur Général | - |
| VIFOR PHARMA | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Vifor Pharma AG
Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
University of St. Gallen
University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bellevue Group AG
Bellevue Group AG Investment ManagersFinance Provides asset management services | Finance |
Asceneuron SA
Asceneuron SA BiotechnologyHealth Technology Develops therapeutics for neurodegenerative disorders | Health Technology |
medmix AG
medmix AG Medical SpecialtiesHealth Technology Manufactures and supplies surgical, dental and drug delivery devices | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national